Population pharmacokinetics (PK) of nevirapine (NVP) in HIV-infected adults

被引：0
|
作者：
Schipani, A. [1 ]
Wakeham, K. [2 ,3 ]
Ggayi, A. [2 ]
Kamali, A. [2 ]
Lalloo, D. G. [3 ]
Youle, M. [4 ]
Johnson, M. [4 ]
Khoo, S. [1 ]
Dickinson, L. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England
[2] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda
[3] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[4] Royal Free Hosp, Dept HIV Med, London NW3 2QG, England
来源：
HIV MEDICINE | 2009年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetics of nevirapine in Thai HIV-infected patients
    Wattanakul, Thanaporn
    Avihingsanon, Anchalee
    Manosuthi, Weerawat
    Punyawudho, Baralee
    [J]. ANTIVIRAL THERAPY, 2014, 19 (07) : 651 - 660
  • [2] Safety and pharmacokinetics (PK) of nevirapine (NVP) in HIV-1 infected pregnant women and their newborns.
    Mirochnick, M
    Sullivan, J
    Cort, S
    McNamara, J
    Fenton, T
    Sperling, R
    [J]. PEDIATRIC RESEARCH, 1996, 39 (04) : 444 - 444
  • [3] SAFETY AND PHARMACOKINETICS (PK) OF NEVIRAPINE (NVP) IN NEONATES BORN TO HIV-1 INFECTED WOMEN. ♦ 744
    Mark Mirochnick
    John Sullivan
    Paul Gagnier
    Terry Fenton
    Rhoda Sperling
    [J]. Pediatric Research, 1997, 41 (Suppl 4) : 126 - 126
  • [4] Once- or twice-daily dosing of nevirapine in HIV-infected adults:: a population pharmacokinetics approach
    Molto, Jose
    Valle, Marta
    Miranda, Cristina
    Cedeno, Samandhy
    Miranda, Jose
    Ramon Santos, Jose
    Negredo, Eugenia
    Vilaro, Josep
    Costa, Joan
    Clotet, Bonaventura
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (04) : 784 - 792
  • [5] Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach
    Dailly, E.
    Raffi, F.
    Perre, P.
    Martin, J.
    Deslandes, G.
    Jolliet, P.
    [J]. HIV MEDICINE, 2009, 10 (09) : 586 - 589
  • [6] Population pharmacokinetics of 25-hydroxycholecalciferol in HIV-infected adults
    Foissac, F.
    Treluyer, J. M.
    Rostane, H.
    Urien, S.
    Viard, J. P.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 117 - 117
  • [7] Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals
    Vogel, Martin
    Bertram, Norbert
    Wasmuth, Jan-Christian
    Wyen, Christoph
    Voigt, Esther
    Schwarze-Zander, Carolynne
    Sudhop, Thomas
    Faetkenheuer, Gerd
    Rockstroh, Juergen K.
    Reichel, Christoph
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) : 988 - 991
  • [8] Combined antiretroviral therapy with nevirapine of HIV-infected adults
    Kravchenko, AV
    [J]. TERAPEVTICHESKII ARKHIV, 2004, 76 (11): : 68 - 71
  • [9] Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
    Schipani, Alessandro
    Wyen, Christoph
    Mahungu, Tabitha
    Hendra, Heidy
    Egan, Deirdre
    Siccardi, Marco
    Davies, Gerry
    Khoo, Saye
    Faetkenheuer, Gerd
    Youle, Michael
    Rockstroh, Juergen
    Brockmeyer, Norbert H.
    Johnson, Margaret A.
    Owen, Andrew
    Back, David J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) : 1332 - 1339
  • [10] Population pharmacokinetics of nevirapine, zidovudine and didanosine after combination therapy in HIV-infected patients.
    Zhou, XJ
    Sheiner, LB
    D'Aquila, RT
    Hughes, MD
    Hirsch, MS
    Fischl, MA
    Johnson, VA
    Myers, M
    Sommadossi, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 182 - 182
12345